Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2025 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
Meg Heim
Meg Heim as VP, Global Head Strategic Scientific Engagement, Operations and Program Management, is a key member of the CMO Office. Meg’s role participates as a member of various Global teams and committees to further strengthen and globalize the Medical function across all Business Units and Countries.
Meg is responsible for crafting and executing the Integrated Scientific Strategy, harmonize Medical Systems, CRMs, Transparency Systems and lead the Innovative Scientific Congress model of the future.
Meg has held officer roles and Executive Global Medical, Sales and Marketing positions with a number of healthcare, medical device and health information technology companies.
Meg is a Registered Nurse with a Masters in Administrative Science, with Post Masters certificates in Non-Profit Organizational Development and Global Leadership from Fairleigh Dickinson University.
Ann Ford
Ann Ford recently served as Chief Ethics and Compliance Officer at Medline Industries, Inc., in Northfield, IL. After completing her nursing education at Marquette University in Milwaukee, WI, she received her Juris Doctor degree from DePaul University College of Law in Chicago, IL.
Until she became an attorney, Ms Ford worked in high-risk obstetrics, pediatric intensive care, and neonatal intensive care. Upon graduating from law school, she spent 11 years in private practice representing physicians, nurses, and hospitals. After private practice, Ms Ford transitioned to in-house legal and compliance roles, including Vice President, General Counsel for two Chicago-area hospitals. In her previous role as Chief Ethics and Compliance Officer at Medline, she oversaw the global ethics and compliance program. In addition, she had been intimately involved with the development of a Medical Affairs function at Medline.
Ms Ford has served on various committees throughout her career, including the hospitals’ Institutional Review Boards. She is a frequent speaker on healthcare legal and compliance topics.
Faisal Mehmud
Faisal joined BMS in July 2016 initially to lead the UK and Ireland Medical organisation, and is now Head of the European Medical group.
He has held a variety of senior leadership roles, most recently at Novartis in the USA, where he was the Vice President of US Clinical Development and Medical Affairs Oncology. Previously he was at GSK, where he was Head of the USA North American Medical Affairs/Clinical Development group for Oncology & Haematology and prior to this he held several roles of increasing seniority at GSK in the UK and at Sanofi in the UK and Paris, France (corporate).
He has extensive experience in late phase drug development, interaction with regulators, HTA bodies and academic co-operative groups globally over 15 years in a variety of therapeutic areas.
Faisal graduated in Medicine from Cambridge University, and before his time in industry, was a practicing physician in the UK in general medicine and oncology.
